Alessandro Laganà

10PUBLICATIONS
87CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical mycologyCancer geneticsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 08, 2026
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

|Dec 09, 2025
Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma.

Denis J Ohlstrom, William C Pilcher, Marina E Michaud

|Nov 05, 2025
Long-term remission after cilta-cel in multiple myeloma is linked to diverse T cells and low myeloid suppression.

Junia Vieira Dos Santos, David T Melnekoff, Adolfo Aleman

|Dec 26, 2024
The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward.

Meghana Ram, Molly R Fraser, Junia Vieira Dos Santos

|Sep 16, 2024
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes.

Santiago Thibaud, Ryan L Subaran, Scott Newman

|Feb 09, 2023
The genome of IMiD-refractory myeloma.

Alessandro Laganà

Pageof 2

Frequent Collaborators

5 joint publications

Hearn Jay Cho

4 joint publications

Adolfo Aleman

4 joint publications

Joshua Richter

3 joint publications

Santiago Thibaud